Laura A Hexamer

USPTO Granted Patents = 22 (Patent Applications = 12)

CIPO Patents = 4 (Patent Applications = 9)

EPO Patents = 10 (Patent Applications = 15)

Average Co-Inventor Count = 11.9

ph-index = 11

Forward Citations = 440(Granted Patents)

Location History:

Gurnee, IL (US) (2008)
Grayslake, IL (US) (2011 - 2024)

Company Filing History:

Abbott Laboratories Corporation

patents

3 out of 80

The Walter and Eliza Hall Institute of Medical Research

where one patent can have more than one assignee

Years Active: 2008-2024

Loading Chart...

22 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11897864 - Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases (2024-02-13),

2. 9315488 - Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases (2016-04-19),

3. 9303025 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases (2016-04-05),

4. 9174982 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases (2015-11-03),

5. 9156856 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases (2015-10-13),

6. 9125913 - Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases (2015-09-08),

7. 9073855 - BCL-2 selective apoptosis-inducing agents for the treatment of cancer and immune diseases (2015-07-07),

8. 9072748 - BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases (2015-07-07),

9. 9045420 - Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases (2015-06-02),

10. 9029404 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases (2015-05-12),

11. 8952157 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases (2015-02-10),

12. 8586754 - BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases (2013-11-19),

13. 8563735 - Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases (2013-10-22),

14. 8557983 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases (2013-10-15),

15. 8546399 - Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases (2013-10-01),

Title: The Innovative Journey of Laura A Hexamer

Introduction: Laura A Hexamer, a talented inventor hailing from Grayslake, IL (US), has made significant contributions to the field of innovations with her creative mindset and dedication.

Latest Patents: Laura A Hexamer holds several patents in various technological areas, showcasing her versatility and expertise in inventing cutting-edge solutions to real-world problems.

Career Highlights: Throughout her career, Laura A Hexamer has demonstrated a keen eye for identifying gaps in the market and developing unique inventions to fill those voids. Her innovative spirit has led to the creation of groundbreaking technologies that have improved the lives of many.

Collaborations: Laura A Hexamer has collaborated with leading research institutions and universities to further her inventions and bring them to the market. Her partnerships have been instrumental in turning her ideas into tangible products that have made a positive impact on society.

Conclusion: Laura A Hexamer's journey as an inventor is a testament to her passion for innovation and her relentless pursuit of excellence. Her contributions to the field continue to inspire aspiring inventors and pave the way for future groundbreaking discoveries.

This text is generated by artificial intelligence and may not be accurate.